Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | FSCN1 | Q16658 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7599236 | 0.85 | HTT (0.44) | GAAMEN1KMT2APOLBMAPT | |
| SCHEMBL4074003 | 0.83 | SMN1; SMN2 (0.39) | TSHRGAAMEN1KMT2APOLB | |
| SCHEMBL11705566 | 0.80 | ALDH1A1 (0.56) | MEN1KMT2APOLBMAPTALDH1A1 | |
| SCHEMBL11208904 | 0.78 | CYP2C9 (0.40) | TSHRMEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL11332144 | 0.77 | ALDH1A1 (0.40) | GAAMAPTALDH1A1LMNAHTT | |
| SCHEMBL28434079 | 0.76 | TRPM8 (0.45) | TSHRGAAMEN1KMT2AALDH1A1 | |
| SCHEMBL11427097 | 0.74 | HCRTR1 (0.38) | TSHRMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL10956297 | 0.72 | CYP3A4 (0.38) | TSHRMAPTALDH1A1LMNA | |
| SCHEMBL11429495 | 0.72 | MAPT (0.44) | TSHRGAAMEN1KMT2AMAPT | |
| SCHEMBL11857851 | 0.72 | FSCN1 (0.41) | TSHRGAAMEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6437104-B1 | DIAZOTIZATION OF AROMATIC AMINE, AZO COUPLING TO FORM AN AZOCARBOXYLIC ACID OR AZODICARBOXYLIC ACID, FORMATION OF AN AZOCARBONYL CHLORIDE OR AZODICARBONYL DICHLORIDE AND CONDENSATION WITH AROMATIC DIAMINE | CLARIANT GMBH (DE) | 2002-08-20 | — | — | US | disclosed |
| US-20020058794-A1 | Preparation of disazo condensation pigments in microreactors | CLARIANT INTERNATIONAL LTD. | 2002-05-16 | — | — | US | disclosed |
| US-4003886-A | Tetracarboxylic acid ester substituted disazo pigments | CIBA-GEIGY AG (CH) | 1977-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058794-A1 | Preparation of disazo condensation pigments in microreactors | DDT, DDC, DKC1 | TSHR 2075/4885GAA 1870/4885MEN1 681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.